Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing

BackgroundAlternative splicing contributes significantly to the complexity of the human transcriptome and proteome. Computational prediction of alternative splice isoforms are usually based on EST sequences that also allow to approximate the expression pattern of the related transcripts. However, the limited number of tissues represented in the EST data as well as the different cDNA construction protocols may influence the predictive capacity of ESTs to unravel tissue-specifically expressed transcripts.MethodsWe predict tissue and tumor specific splice isoforms based on the genomic mapping (SpliceNest) of the EST consensus sequences and library annotation provided in the GeneNest database. We further ascertain the potentially rare tissue specific transcripts as the ones represented only by ESTs derived from normalized libraries. A subset of the predicted tissue and tumor specific isoforms are then validated via RT-PCR experiments over a spectrum of 40 tissue types.ResultsOur strategy revealed 427 genes with at least one tissue specific transcript as well as 1120 genes showing tumor specific isoforms. While our experimental evaluation of computationally predicted tissue-specific isoforms revealed a high success rate in confirming the expression of these isoforms in the respective tissue, the strategy frequently failed to detect the expected restricted expression pattern. The analysis of putative lowly expressed transcripts using normalized cDNA libraries suggests that our ability to detect tissue-specific isoforms strongly depends on the expression level of the respective transcript as well as on the sensitivity of the experimental methods. Especially splice isoforms predicted to be disease-specific tend to represent transcripts that are expressed in a set of healthy tissues rather than novel isoforms.ConclusionsWe propose to combine the computational prediction of alternative splice isoforms with experimental validation for efficient delineation of an accurate set of tissue-specific transcripts.

[1]  H. Cedar,et al.  Methylation patterns of testis-specific genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Tyshenko,et al.  Dihydrofolate reductase of Drosophila. Cloning and expression of a gene with a rare transcript. , 1994, The Journal of biological chemistry.

[3]  M. Soares,et al.  Normalization and subtraction: two approaches to facilitate gene discovery. , 1996, Genome research.

[4]  J. Beavo,et al.  The Calmodulin-dependent Phosphodiesterase Gene PDE1C Encodes Several Functionally Different Splice Variants in a Tissue-specific Manner* , 1996, The Journal of Biological Chemistry.

[5]  H. Wang,et al.  Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. , 1997, Growth factors.

[6]  H. Sive,et al.  Subtractive cloning: past, present, and future. , 1997, Annual review of biochemistry.

[7]  Y. Bergman,et al.  DNA methylation: regulation of gene expression and role in the immune system. , 1997, Biochimica et biophysica acta.

[8]  T. Cooper,et al.  The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.

[9]  M. Kadiri,et al.  Analysis of a human cDNA containing a tissue-specific alternatively spliced LIM domain. , 1998, Biochemical and biophysical research communications.

[10]  C. Pilarsky,et al.  Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. , 1999, Nucleic acids research.

[11]  M Vingron,et al.  GeneNest: automated generation and visualization of gene indices. , 2000, Trends in genetics : TIG.

[12]  A. Karpova,et al.  Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene. , 2000, Genes & development.

[13]  A. Ryo,et al.  Use of serial analysis of gene expression (SAGE) technology. , 2001, Journal of immunological methods.

[14]  R. Harvey,et al.  Differential Binding of an SRF/NK-2/MEF2 Transcription Factor Complex in Normal Versus Neoplastic Smooth Muscle Tissues* , 2001, The Journal of Biological Chemistry.

[15]  Christopher J. Lee,et al.  Genome-wide detection of alternative splicing in expressed sequences of human genes , 2001, Nucleic Acids Res..

[16]  H. Moriwaki,et al.  Analysis of Gene Expression Profile Induced by Hepatocyte Nuclear Factor 4α in Hepatoma Cells Using an Oligonucleotide Microarray* , 2002, The Journal of Biological Chemistry.

[17]  Martin Vingron,et al.  SpliceNest: visualizing gene structure and alternative splicing based on EST clusters , 2002 .

[18]  S. Brenner,et al.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Jean-Michel Claverie,et al.  Heart-specific genes revealed by expressed sequence tag (EST) sampling , 2002, Genome Biology.

[20]  M. Pfreundschuh,et al.  A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing , 2002, Oncogene.

[21]  Christopher J. Lee,et al.  Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. , 2002, Nucleic acids research.

[22]  David States,et al.  Selecting for functional alternative splices in ESTs. , 2002, Genome research.

[23]  Wafik S El-Deiry,et al.  Derangement of growth and differentiation control in oncogenesis , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[25]  Christopher J. Lee,et al.  Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. , 2003, Nucleic acids research.

[26]  Milena D. Bister,et al.  Rio2p, an Evolutionarily Conserved, Low Abundant Protein Kinase Essential for Processing of 20 S Pre-rRNA in Saccharomyces cerevisiae* , 2003, Journal of Biological Chemistry.

[27]  X. Jeunemaître,et al.  Multiple Promoters in the WNK1 Gene: One Controls Expression of a Kidney-Specific Kinase-Defective Isoform , 2003, Molecular and Cellular Biology.

[28]  K. Buetow,et al.  Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. , 2003, Cancer research.

[29]  G. Mize,et al.  The Two Upstream Open Reading Frames of Oncogene mdm2 Have Different Translational Regulatory Properties* , 2003, Journal of Biological Chemistry.

[30]  Martin Vingron,et al.  Genome-scale design of PCR primers and long oligomers for DNA microarrays. , 2003, Nucleic acids research.

[31]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[32]  S. Brenner,et al.  An unappreciated role for RNA surveillance , 2004, Genome Biology.

[33]  M. Malumbres,et al.  Cell cycle deregulation: a common motif in cancer. , 2003, Progress in cell cycle research.

[34]  R. Yamazaki,et al.  Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies , 2003, Leukemia & lymphoma.

[35]  Martin Vingron,et al.  Genome wide identification and classification of alternative splicing based on EST data , 2004, Bioinform..

[36]  Thangavel Alphonse Thanaraj,et al.  ASD: the Alternative Splicing Database , 2004, Nucleic Acids Res..